THE STORY IN BRIEF
  • Alzheimer’s Disease International released its 2026 report on dementia clinical trials on 21 September.
  • Some trials ask a study partner who knows the participant to attend visits and describe changes over time.
  • Practical details such as travel, appointment frequency, consent and reimbursement can shape who is able to participate.
MAKE TIME FOR A GOOD READ
Inside this story 2 perspectives

A family considering dementia research may begin by asking whether the person with memory problems qualifies. There is often a second question. Does somebody who knows that person well have the time and means to take part too? Many Alzheimer’s trials ask a study partner to attend visits or describe changes between appointments. The answer can depend as much on a family’s work and travel arrangements as on its willingness to help.

Alzheimer’s Disease International published its World Alzheimer Report on 21 September. The 2026 edition examines clinical trials through essays and case studies, including recruitment, consent, retention and the representation of different populations. These questions matter to the evidence future patients will rely on. If participation requires a second adult who can repeatedly take time off or travel a long way, a research team may hear from only part of the population it wants to understand.

What a study partner is being asked to notice

A clinical assessment can capture what a participant does during a scheduled visit. Someone who sees the person regularly may notice a change in how they manage a familiar journey, follow a conversation or carry out a household task. The US National Institute on Aging’s guide explains that many studies ask a caregiver or family member to accompany a participant and help describe changes over time. Requirements vary between studies.

Enquiring about a study is a separate step from enrolling. At the University of California San Francisco’s Memory and Aging Center, for example, completing an initial survey does not enrol the person. The team can follow up to check eligibility, explain the research and answer questions. A family can use that conversation to ask who is required at which visits, what happens during an appointment and what contact is needed between visits.

The journey is part of participation

A morning assessment can effectively occupy a working day once both people have travelled there and home. Some studies reimburse travel expenses or compensate participants, while arrangements differ. Asking whether costs are covered up front or repaid later gives more information than simply asking whether a study is free. A participant who needs an interpreter or a companion may also want to know whether the same support is available at each appointment.

The purpose of a trial is to answer a research question. Eligible participants have to understand what is being asked, the possible risks and the voluntary nature of participation. Research teams should explain consent procedures and what happens if a participant wishes to withdraw. Nobody can promise a personal treatment benefit from joining.

For someone considering a first call, a useful opening is to describe a normal week, including the demands on the person supporting them. That gives both sides a chance to work out whether the research can fit the lives of the people it needs.

BB
ABOUT THE AUTHOR

Beyond Business Editors

Editorial desk

Beyond Business connects global developments with the decisions, ambitions and everyday lives of its readers. Our editorial desk explores the stories shaping our world.

More from this author
Keep the perspective.